Summary:

- Researchers from the Weizmann Institute of Science in Israel have identified biomarkers for Alzheimer's disease up to 20 years before the onset of clinical symptoms.
- The study, published in the journal Nature Medicine, used machine learning algorithms to analyze blood samples and found that changes in specific lipid molecules can predict the future development of Alzheimer's with high accuracy.
- This discovery could lead to early detection and intervention, allowing for more effective treatment and potentially delaying or preventing the progression of the disease.